Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.

Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Urinalysis instrumentation, 2023

[one_third]

[/one_third]

[one_third]

[/one_third]

[one_third_last]

[/one_third_last]

[wpdatatable id=67]

[one_third]


[/one_third]

[two_third_last]

In urinalysis, reflex algorithms and other efficiencies

March 2023—Urinalysis was at the heart of a Feb. 7 discussion between CAP TODAY publisher Bob McGonnagle; Ron Jackups Jr., MD, PhD, of Washington University School of Medicine; and Jason Anderson of Sysmex America. “There’s a lot of room to explore what the optimal parameters are to use with the best specificity and sensitivity for a reflex to the sediment analysis or the culture,” Anderson said. Here’s what he and Dr. Jackups said about reflex testing, automation, and middleware.

Since the urinalysis roundtable in December 2021, three things continue to be hot issues regardless of instrumentation, field of analysis, and subspecialty. Number one is automation in workflow, having something that’s robust for high volume, low staffing. Number two is the need for fit of an instrument line. In other words, there’s a core lab urinalysis instrument that’s ideal and yet there are smaller clinics, hospitals, all kinds of sites that can benefit from the same technology but in a differently configured unit. Number three is understanding if we’re extracting the optimum clinical information from the analysis in fields like hematology and urinalysis.

Dr. Jackups

Ron Jackups, talk to us about reflex testing in urinalysis and then more specifically about what you’ve been working on at Barnes-Jewish Hospital.
Ron Jackups Jr., MD, PhD, associate professor of pathology and immunology, Washington University School of Medicine, and associate chief medical information officer for laboratory informatics, BJC HealthCare: Reflex testing in general has two big benefits. The first is it focuses the diagnostic process, which reduces waste. We have seen in urinalysis and other areas that providers, rather than order a test and wait for the result and then order another test based on that result and wait for the next result, et cetera, tend to do what we call shotgun testing—they order all the tests they think might be relevant at once and then react to the results after they get them. This is wasteful in many situations if the tests further down the line were not necessary and can also be dangerous if one of the tests down the line is a false-positive. Part of the goal of reflex testing is to identify situations where there’s a low diagnostic value and high risk of false-positives in future tests that could be prevented by simply not doing them. That’s the first reason to do reflex testing.
Continue reading …
[/two_third_last]